No abstract available
MeSH terms
-
Betacoronavirus* / drug effects
-
Betacoronavirus* / immunology
-
COVID-19
-
Coronavirus Infections / drug therapy*
-
Coronavirus Infections / immunology
-
Humans
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use*
-
Multiple Sclerosis / drug therapy*
-
Multiple Sclerosis / immunology
-
Pandemics
-
Pneumonia, Viral / drug therapy*
-
Pneumonia, Viral / immunology
-
Practice Guidelines as Topic / standards*
-
SARS-CoV-2
-
Severe Acute Respiratory Syndrome / drug therapy
-
Severe Acute Respiratory Syndrome / immunology
-
Severe acute respiratory syndrome-related coronavirus / drug effects
-
Severe acute respiratory syndrome-related coronavirus / immunology